Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Lakefront to Present at the 2026 Jefferies Global Healthcare Conference in London
GlobeNewswire, Inc.
Mechelen, Belgium; November 10, 2026, 22.01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the Company will host a fireside chat at the 2026 Jefferies Global Healthcare Conference in London at 2:00 pm GMT (9:00 am...
Investing in soil health can become an economic opportunity for European agriculture
EIN Presswire
BRUXELLES, BELGIUM, November 10, 2026 /EINPresswire.com/ -- Investing in soil health can generate long-term economic benefits and help make agriculture more resilient to climate change.
Ziphius, a leading saRNA biotech, today announces the appointment of Mr. Antoon Loomans to its Board of Directors
GlobeNewswire, Inc.
GHENT, Belgium and WILMINGTON, Del., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Ziphius, a biotech company developing self-amplifying RNA (saRNA) vaccines and therapeutics, today announced the appointment of Mr. Antoon Loomans to its Board of Directors,...
Major Power Outage Disrupts Electricity Supply Across Belgium
MENAFN
(MENAFN) Approximately 20,000 households lost electricity on Thursday after a widespread power failure affected four municipalities in Belgium's East Flanders province, prompting emergency responses and disrupting essential services.
MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines
GlobeNewswire, Inc.
Ghent, Belgium – November 5, 2026, Nov. 05, 2026 (GLOBE NEWSWIRE) -- MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines Collaboration combines MRM Health’s...
Incyclix Bio Establishes Steering Committee of Leading Breast Cancer Experts to Guide INX-315 Clinical Development
GlobeNewswire, Inc.
RESEARCH TRIANGLE PARK, N.C., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Incyclix Bio, LLC, a next-generation cell cycle control company developing INX-315, a novel, potent and selective CDK2 inhibitor for the treatment of advanced and resistant cancer,...
MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines
GlobeNewswire, Inc.
Ghent, Belgium – November 5, 2026 , Nov. 05, 2026 (GLOBE NEWSWIRE) -- MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines Collaboration combines MRM Health’s...
Blackout Hits 20,000 Belgian Families After Cable Strike
MENAFN
(MENAFN) A high-voltage cable strike plunged roughly 20,000 families in Belgium’s East Flanders province into darkness on Thursday, according to local authorities and energy distributor Fluvius, as cited by a public broadcaster.
Lakefront Initiates New €50 Million Share Repurchase Program Following Completion of Initial Share Repurchase Program
GlobeNewswire, Inc.
Mechelen, Belgium; November 16, 2026; 7.30 AM CET regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced the initiation of a new share repurchase program of up to €50 million, following completion of its...
Rejuvenate Biomed Completes Last Patient Visit in Phase 2 Trial of RJx-01 in COPD-Related Muscle Weakness and Advances Regulatory Discussions for Sarcopenia
GlobeNewswire, Inc.
Last patient has completed the final study visit in the Phase 2 trial in older adults with COPD-induced muscle weakness, and is on track to report topline data by year-end 2026 Placebo-controlled Phase 2 trial is assessing RJx-01’s safety profile...
Evestia Clinical Acquires Emtex Life Science to Further Enhance its Global Full-Service Clinical Research Capabilities
GlobeNewswire, Inc.
Acquisition significantly expands the depth and scale of Evestia Clinical’s established medical writing capabilities for biotech innovators and pharmaceutical companies The deal expands Evestia Clinical’s European presence LONDON, Nov. 03, 2026...
Strengthening acquisition, research efforts will support warfighter readiness and military healthcare services
DVIDS - Georgia
As retired Army Col. Matthew Clark assumed the role of assistant director for the Defense Health Agency's research, development, and acquisition enterprise, he stressed “the job is about delivering results and delivering support.” Sworn in by DHA...
Meet the Winners of the 2026 AKC® Humane Fund Awards for Canine Excellence (ACE)
GlobeNewswire, Inc.
NEW YORK, Nov. 16, 2026 (GLOBE NEWSWIRE) -- The AKC® Humane Fund is proud to announce the winners of the 27th annual AKC® Humane Fund Awards for Canine Excellence (ACE). These awards celebrate six loyal, hard-working dogs and one incredible team...
Healthcare and Life Sciences Leaders Build on NVIDIA to Advance Drug Discovery and Expand Patient Care
GlobeNewswire, Inc.
News Summary: NVIDIA and the UW Medicine Institute for Protein Design debut RFD4-Proteina, a new open model that combines programmable protein design with search capabilities, unlocking new frontiers in biology.
AKC Canine Health Foundation Announces Semifinalists for 2026 Canine Health Discovery of the Year Award
GlobeNewswire, Inc.
RALEIGH, N.C., Oct. 22, 2026 (GLOBE NEWSWIRE) -- The AKC Canine Health Foundation (CHF) today named eight semifinalists for the 2026 Canine Health Discovery of the Year Award, which honors the year’s most important advancements in canine health....
Top 9 Sanitary Napkin OEM/ODM Manufacturing Providers in 2026
EIN Presswire
A market-focused overview of OEM/ODM capabilities and bulk export considerations for sanitary napkin distributors.
Final Safety, Pharmacokinetic and Pharmacodynamic Data from COL-5671 Phase 1 Clinical Study Presented at UEGW
GlobeNewswire, Inc.
COL-5671, a highly selective oral SIK3 inhibitor, demonstrated a favorable safety and pharmacokinetic (PK) profile Pharmacodynamic (PD) data indicate potent TNFα suppression at low doses, with even greater IL-23 suppression observed in cellular...
EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe
GlobeNewswire, Inc.
October 15, 2026 Five-year research project unites 42 public and private partners across 17 countries to conduct 22 clinical studies involving 14,000+ patients; first patients will be enrolled this month Project aims to help cardiac patients avoid...
Agomab Announces First Patient Dosed in Global NOV-ERA Phase 2b Study of Ontunisertib in Fibrostenosing Crohn's Disease
GlobeNewswire, Inc.
-- NOV-ERA is designed to assess the efficacy and safety of ontunisertib in approximately 320 patients with symptomatic Fibrostenosing Crohn's disease (FSCD) -- -- Global, randomized, placebo-controlled, dose-ranging study to evaluate three dose...
Belgian Army trains for readiness and responds to real-world emergency during Yellow Condor
DVIDS - Georgia
GRAFENWOEHR, Germany— Belgian Army soldiers assigned to 3 Para, Special Operations Regiment are using 7th Army Training Command's Grafenwoehr Training Area to build combat readiness during Exercise Yellow Condor, a Belgian training event designed...
Sign up for:
Belgium Health Review
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.